| Structural prediction and mutational analysis of Rv3906c gene of Mycobacterium tuberculosis H37Rv to determine its essentiality in survival M Beg, Shivangi, SC Thakur, LS Meena Advances in bioinformatics 2018, 2018 | 49 | 2018 |
| A novel approach in treatment of tuberculosis by targeting drugs to infected macrophages using biodegradable nanoparticles Shivangi, LS Meena Applied biochemistry and biotechnology 185 (3), 815-821, 2018 | 24 | 2018 |
| Structural and Functional Annotation O f Rv1514c Gene of Mycobacterium tuberculosis H37Rv As Glycosyl Transferases MA Beg, Shivangi, F Athar, LS Meena Journal of Advanced research in biotechnology 3 (2), 1-9, 2018 | 15 | 2018 |
| Mutational effects on structural stability of SRP pathway dependent co-translational protein ftsY of Mycobacterium tuberculosis H37Rv Shivangi, MA Beg, LS Meena Gene Reports 15, 100395, 2019 | 14 | 2019 |
| Systematical analysis to assist the significance of Rv1907c gene with the pathogenic potentials of Mycobacterium tuberculosis H37Rv MA Beg, Shivangi, T SC, LS Meena J Biotechnol Biomater 8 (287), 2, 2019 | 14 | 2019 |
| Insights of Rv2921c (FtsY) Gene of Mycobacterium tuberculosis H37Rv to prove its significance by computational approach Shivangi, MA Beg, LS Meena Biomedical Journal of Scientific & Technical Research 12 (2), 9147-9157, 2018 | 14 | 2018 |
| A comprehensive review of COVID‐19 in India: A frequent catch of the information Shivangi, LS Meena Biotechnology and Applied Biochemistry, 2021 | 13 | 2021 |
| Essential biochemical, biophysical and computational inputs on efficient functioning of Mycobacterium tuberculosis H37Rv FtsY Shivangi, LS Meena International Journal of Biological Macromolecules 171, 59-73, 2021 | 7 | 2021 |
| Multidirectional Benefits of Nanotechnology in the Diagnosis, Treatment and Prevention of Tuberculosis M Gupta, Shivangi, LS Meena Journal of Nanotechnology and Nanomaterials 1 (2), 2020 | 6 | 2020 |
| Potential Efficacy of β-Amyrin Targeting Mycobacterial Universal Stress Protein by In Vitro and In Silico Approach S Beg, MA Molecules, 2022 | 5* | 2022 |
| Interconnection of Mycobacterium tuberculosis with host immune system A Kumar, Shivangi, P Agarwal, LS Meena Journal of Respiratory Diseases and Medicine 2 (1), 1-6, 2020 | 5 | 2020 |
| Delivery of antituberculosis drugs to Mycobacterium tuberculosis H37Rv infected macrophages via polylactide-co-glycolide (PLGA) nanoparticles H Verma, Shivangi, M LS Int J Mol Biol Open Access 3 (5), 235-238, 2018 | 3 | 2018 |
| Interaction of Mycobacterium tuberculosis H37Rv with Microfold Cell leads to a New Era of Infection in Host S Meena, Shivangi, LS Meena Ann Clin Lab Res 6 (3), 246, 2018 | 3 | 2018 |
| Vitamin D-An Immune Modulator and Growth Inhibitor of Mycobacterium Tuberculosis H37Rv P Soni, Shivangi, M LS J Mol Biol Biotech 3 (1), 4, 2018 | 3 | 2018 |
| Cholesterol Metabolism: As a Promising Target Candidate for Tuberculosis Treatment by Nanomedicine. J Nanomater Mol Nanotechnol 8: 4 P Tanwar, Shivangi, LS Meena of 8, 2, 2019 | 2* | 2019 |
| Calcium ATPase signaling: A must include mechanism in the Radar of therapeutics development against Tuberculosis Shivangi, LS Meena Biotechnology and Applied Biochemistry, 2021 | 1 | 2021 |
| Revelation of point mutations effect in Mycobacterium tuberculosis MfpA protein that involved in mycobacterial DNA supercoiling and fluoroquinolone resistance Shivangi, P Gautam, M LS Biotechnology and Applied Biochemistry, 2020 | 1* | 2020 |
| Correlated Diabetes Mellitus and Tuberculosis: The Challenge Continues A Pandey, Shivangi, LS Meena J Mol Cell Biochem 2 (1), 7, 2018 | 1 | 2018 |
| Novel and Emerging Approach in the Diagnosis and Prognosis of Tuberculosis by Using Biomarkers S Meena, Shivangi, M LS J Tuberc Ther 3 (119), 2, 2018 | 1 | 2018 |
| Structural and functional characterization of mycobacterial PhoH2 and identification of potential inhibitor of its enzymatic activity. MK Shivangi, Khan, Y., Ekka Braz J Microbiol, 2024 | | 2024 |
Md Amjad BegRutgers Cancer Institute of New JerseyVerified email at cinj.rutgers.edu
